| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/14/2011 | WO2011042474A1 Novel estrogen receptor ligands |
| 04/14/2011 | WO2011041914A1 Use of flubendazole and vinca alkaloids for treatment of hematological diseases |
| 04/14/2011 | WO2011041907A1 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer |
| 04/14/2011 | WO2011041897A1 Compositions and methods for the transport of therapeutic agents |
| 04/14/2011 | WO2011041894A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | WO2010140834A9 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
| 04/14/2011 | WO2010137979A3 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercaemia |
| 04/14/2011 | WO2010120649A3 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
| 04/14/2011 | WO2009126705A8 Induction of tumor hypoxia for cancer therapy |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110086921 Novel Polymorphic Forms of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/14/2011 | US20110086915 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/14/2011 | US20110086912 Derivatives of Propane Diyl Dicinnamate |
| 04/14/2011 | US20110086909 Synthesis of fr901464 and analogs with antitumor activity |
| 04/14/2011 | US20110086902 Compounds for the modulation of beta-catenin expression |
| 04/14/2011 | US20110086899 Pharmaceutical compositions for oral administration |
| 04/14/2011 | US20110086897 (E)-N-(2-Amino-phenyl)-3--acrylamide salts |
| 04/14/2011 | US20110086893 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/14/2011 | US20110086883 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
| 04/14/2011 | US20110086876 Stable sns-595 compositions and methods of preparation |
| 04/14/2011 | US20110086872 Berberine as a selective lung cancer agent and other compositions and methods |
| 04/14/2011 | US20110086870 Combination Therapy |
| 04/14/2011 | US20110086869 Methods for treating viral disorders |
| 04/14/2011 | US20110086868 Specific inhibitors for vascular endothelial growth factor receptors |
| 04/14/2011 | US20110086866 Inhibitors of bruton's tyrosine kinase |
| 04/14/2011 | US20110086865 Ant-ligands molecules and biological applications |
| 04/14/2011 | US20110086864 N-hydroxyamide derivatives and use thereof |
| 04/14/2011 | US20110086861 Pharmaceutical compositions and methods for the treatment of cancer |
| 04/14/2011 | US20110086857 N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| 04/14/2011 | US20110086856 Compositions useful as inhibitors of protein kinases |
| 04/14/2011 | US20110086855 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 04/14/2011 | US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/14/2011 | US20110086853 Therapeutic Compounds |
| 04/14/2011 | US20110086850 Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy |
| 04/14/2011 | US20110086845 Compositions and Methods for Treating Neurodegenerating Diseases |
| 04/14/2011 | US20110086843 Thiazole Derivatives and Use Thereof |
| 04/14/2011 | US20110086842 Pyrimidines as PLK inhibitors |
| 04/14/2011 | US20110086841 N-9 substituted purine compounds, compositions and methods of use |
| 04/14/2011 | US20110086840 N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use |
| 04/14/2011 | US20110086838 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086837 Combinations of a pi3k inhibitor and a mek inhibitor |
| 04/14/2011 | US20110086835 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086832 Novel compounds as cannabinoid receptor ligands |
| 04/14/2011 | US20110086826 Liposomal camptothecins and uses thereof |
| 04/14/2011 | US20110086824 (20S,22E)-2-Methylene-19-Nor-22-Ene-1Alpha,25-Dihydroxyvitamin D3 |
| 04/14/2011 | US20110086815 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 04/14/2011 | US20110086810 HYDROXYL, KETO, AND GLUCURONIDE DERIVATIVES OF 3-(4-(7H-PYRROLO[2,3-d] PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
| 04/14/2011 | US20110086805 In vitro method for diagnosing skin cancer |
| 04/14/2011 | US20110086800 Screening method for predicting susceptibility to breast cancer |
| 04/14/2011 | US20110086113 Cannabinoids in combination with non-cannabinoid chemotherapeutic agents (e.g. serm or alkylating agents) |
| 04/14/2011 | US20110086112 Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same |
| 04/14/2011 | US20110086111 Polymeric systems for the delivery of anticancer drugs |
| 04/14/2011 | US20110086110 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086101 Dispersinb, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K-Based Antibiofilm Compositions and Uses Thereof |
| 04/14/2011 | US20110086082 Composition, system, and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility |
| 04/14/2011 | US20110086067 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086061 Cancer Detection Methods and Reagents |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086056 Methods for the early diagnosis of ovarian cancer |
| 04/14/2011 | US20110086055 Her2 peptides |
| 04/14/2011 | US20110086052 Activation of innate and adaptive immune responses by a ginseng extract |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086047 Fc receptor homolog antibodies and uses thereof |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/14/2011 | US20110086043 STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES |
| 04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086032 Anti-fgf19 antibodies and methods using same |
| 04/14/2011 | US20110086031 Inhibition Of The Activity Of The Capsaicin Receptor In The Treatment Of Obesity Or Obesity-Related Diseases And Disorders |
| 04/14/2011 | US20110086030 Inhibition of cancer metastasis |
| 04/14/2011 | US20110086029 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 04/14/2011 | US20110086027 Anti-cxcr4 antibodies |
| 04/14/2011 | US20110086025 Combination Therapy of a Type II Anti-CD20 Antibody with an Anti-BCL-2 Active Agent |
| 04/14/2011 | US20110086022 Methods for diagnosing and treating neuroendocrine cancer |
| 04/14/2011 | US20110086018 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 04/14/2011 | US20110086011 Prevention or Treatment of Immune-Relevant Disease by Modification of Microfloral Populations |
| 04/14/2011 | US20110086004 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/14/2011 | US20110086003 Stabilization of hydrophobic protein therapeutic agents |
| 04/14/2011 | US20110085987 Folic acid-mediated magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications |
| 04/14/2011 | US20110085986 Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides |
| 04/14/2011 | US20110085979 Conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions |
| 04/14/2011 | US20110085975 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 04/14/2011 | US20110085974 Small molecule ligand-drug conjugates for targeted cancer therapy |
| 04/14/2011 | US20110085970 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 04/14/2011 | US20110083984 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 04/14/2011 | DE112008003744T5 Fettemulsion, umfassend Ganoderma-Sporenöl, Verfahren zur Qualitätskontrolle und Verwendung davon Fat emulsion comprising Ganoderma spore oil, quality control procedures and use thereof |
| 04/14/2011 | DE102010044853A1 Hemmung des Überlebens von Hautkrebs durch Cyclohexenonverbindungen aus Antrodia camphorata Inhibition of survival of skin cancer by cyclohexenone from Antrodia camphorata |
| 04/14/2011 | DE102009049662A1 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten 2,5-disubstituted 2H-indazoles as EP2-receptor antagonists |
| 04/14/2011 | CA2784277A1 Pyrazoles derivatives modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 04/14/2011 | CA2777406A1 Thiazolidinedione energy restriction-mimetic agents |
| 04/14/2011 | CA2777198A1 Use of toll-like receptor and agonist for treating cancer |
| 04/14/2011 | CA2777114A1 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 04/14/2011 | CA2777096A1 Compositions and methods for the transport of therapeutic agents |
| 04/14/2011 | CA2777087A1 Combination |